These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18157381)

  • 1. [Evaluation of radioiodine therapy with fixed doses of 10 and 15 mCi in patients with Graves' disease].
    Canadas V; Vilar L; Moura E; Brito A; Castellar E
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1069-76. PubMed ID: 18157381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.
    Nordyke RA; Gilbert FI
    J Nucl Med; 1991 Mar; 32(3):411-6. PubMed ID: 2005449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Hypothyreoidism after Radioactive Iodine-I131 Treatment in Dependance of Hyperthyreoidism Etiology and Therapy Dose.
    Beslic N; Licina S; Sadija A; Milardovic R
    Med Arch; 2017 Aug; 71(4):270-273. PubMed ID: 28974848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
    Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
    Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease.
    Willemsen UF; Knesewitsch P; Kreisig T; Pickardt CR; Kirsch CM
    Eur J Nucl Med; 1993 Nov; 20(11):1051-5. PubMed ID: 8287872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hyperthyroidism with radioiodine: effects of administered dose on complications and thyroid function].
    Pineda P; Michelsen H; Rivera M; Lillo R; Massardo T; Araya V; Sierralta P; Oviedo S; Liberman C
    Rev Med Chil; 2000 May; 128(5):499-507. PubMed ID: 11008353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
    Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
    Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre.
    Danaci M; Feek CM; Notghi A; Merrick MV; Padfield PL; Edwards CR
    N Z Med J; 1988 Nov; 101(858):784-6. PubMed ID: 3194075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
    Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
    Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.